|
Chang, Chih-Hao; Qiu, Jing; O'Sullivan, David et al. (2015) Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell 162:1229-41
|
|
Mittal, Deepak; Gubin, Matthew M; Schreiber, Robert D et al. (2014) New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. Curr Opin Immunol 27:16-25
|
|
Gubin, Matthew M; Zhang, Xiuli; Schuster, Heiko et al. (2014) Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515:577-81
|
|
Lee, Sang Hun; Carrero, Javier A; Uppaluri, Ravindra et al. (2013) Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-? receptor subunit 1 (IFNGR1). J Immunol 191:4223-34
|
|
Teijaro, John R; Ng, Cherie; Lee, Andrew M et al. (2013) Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340:207-11
|
|
Kreisel, Daniel; Gelman, Andrew E; Higashikubo, Ryuji et al. (2012) Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer. Cancer Res 72:4311-7
|
|
O'Sullivan, Timothy; Saddawi-Konefka, Robert; Vermi, William et al. (2012) Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med 209:1869-82
|
|
O'Sullivan, Timothy; Dunn, Gavin P; Lacoursiere, Daphne Y et al. (2011) Cancer immunoediting of the NK group 2D ligand H60a. J Immunol 187:3538-45
|
|
Winkler, Ashley E; Brotman, Joshua J; Pittman, Meredith E et al. (2011) CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Cancer Res 71:5707-16
|
|
Uppaluri, Ravindra; Sheehan, Kathleen C F; Wang, Liqing et al. (2008) Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation 86:137-47
|
Showing the most recent 10 out of 60 publications
